Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey.

BACKGROUND/AIMS The aim of this study was to investigate the risk factors which may be involved in the transmission of hepatitis C virus and to determine the recent distribution of various genotypes in Western Turkey. MATERIALS AND METHODS The risk determination study consisted of 215 patients whose serum samples were sent to the Medical Microbiology Laboratory at Ege University Hospital between 2005 and 2010 and were anti-hepatitis C virus positive. For the determination of recent genotype distribution, genotyping results of all 535 patients sent to the same laboratory from 2007 to 2011 were analyzed. Information on possible risk factors for the transmission of hepatitis C virus was obtained by a telephone questionnaire. Hepatitis C virus typing was performed by restriction fragment length polymorphism analysis. RESULTS The most frequently reported risk factors were history of dental procedures in 171 (79,5%) patients and surgical operations in 137 (63,7%) patients. Genotype 1 was observed in 499 of the 535 patients (93,3%) with chronic hepatitis C virus infection. Of these, 69 patients showed infection with subtype 1a (12.9.%) and 430 - with subtype 1b (80.4%). Genotype 3 was determined in 20 patients (3,7%), genotype 2 - in 8 patients (1,5), and genotype 4 - in 8 patients (1,5%). CONCLUSIONS Even though there is an increase in non-1 genotypes, Turkish patients with chronic hepatitis C still represent a rather homogenous group with genotypic diversity encountered rarely. The risk factors detected in the patients admitted to our hospital are mainly medical procedures which can be prevented by the use of simple infection control practices and implementation of an education program.

[1]  M. Eğri,et al.  Healthcare Related Risk Factors Account for the Majority of HCV Transmissions in Middle Black Sea Region of Turkey: A Case-Control Study , 2011 .

[2]  S. Erensoy,et al.  Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  M. Alter,et al.  Epidemiology of hepatitis C virus infection. , 2007, World journal of gastroenterology.

[4]  M. Alter,et al.  Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low‐risk population , 2006, Hepatology.

[5]  K. Demır,et al.  Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish Population , 2006, Digestive Diseases and Sciences.

[6]  H. Senturk,et al.  Hepatitis C Virus Risk Factors in the Turkish Community , 2005, Digestive Diseases and Sciences.

[7]  P. Gallian,et al.  Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Blood Donors from Southeast France , 2005, Journal of Clinical Microbiology.

[8]  S. Glynn,et al.  A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors , 2005, Transfusion.

[9]  J. Perz Estimated Global Prevalence of Hepatitis C Virus Infection , 2004 .

[10]  C. Yurdaydın,et al.  Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients , 2004, Archives of Virology.

[11]  Matthew G Law,et al.  The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. , 2003, International journal of epidemiology.

[12]  D. Vlahov,et al.  Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. , 2003, American journal of epidemiology.

[13]  T. Bjarnason,et al.  ESPAD report 2003: alcohol and other drug use among students in 35 European countries. , 2003 .

[14]  M. Alter,et al.  Prevention of spread of hepatitis C , 2002, Hepatology.

[15]  N. Terrault,et al.  Sexual activity as a risk factor for hepatitis C , 2002, Hepatology.

[16]  E. Roberts,et al.  Maternal‐infant transmission of hepatitis C virus infection , 2002, Hepatology.

[17]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[18]  W. Halbmayer,et al.  HCV genotypes and age distribution in patients of Vienna and surrounding areas. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  P. Simmonds,et al.  The distribution of hepatitis C virus genotypes in Turkish patients , 1995, Journal of viral hepatitis.

[20]  G. Ippolito,et al.  Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. , 1995, American journal of infection control.

[21]  P. Simmonds Variability of hepatitis C virus , 1995, Hepatology.

[22]  A. Keller,et al.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey , 1994, Journal of clinical microbiology.

[23]  P. Simmonds,et al.  Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities , 1993, Transfusion.

[24]  E. Holmes,et al.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. , 1992, The Journal of general virology.